The Effects of Allopurinol on Levels of Cardiac Troponin Following Non-ST Elevation Myocardial Infarction: A Pilot Randomized Clinical Trial
Background: Given the potential anti-ischemic effects of allopurinol, we aimed to assess whether allopurinol administration may reduce myocardial injury following non-ST elevation myocardial infarction (NSTEMI). Methods: A randomized clinical trial (RCT) was conducted on 100 individuals with NSTEMI....
Saved in:
Main Authors: | Sajad Khiali (Author), Parvin Sarbakhsh (Author), Sina Mashayekhi (Author), Elham Mohamadrezapour (Author), Samaneh Dousti (Author), Taher Entezari-Maleki (Author) |
---|---|
Format: | Book |
Published: |
Tabriz University of Medical Sciences,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Impact of Metformin on Cardiac Troponin-I and ST Resolution in Patients with ST Elevation Myocardial Infarction Undergoing Thrombolytic Therapy
by: Naser Aslanabadi, et al.
Published: (2023) -
Effects of Allopurinol in the Prevention of Periprocedural Myocardial Injury Following Elective Percutaneous Coronary Intervention: A Randomized Clinical Trial
by: Naser Aslanabadi, et al.
Published: (2024) -
Troponin I Cutoff for Non-ST-Segment Elevation Myocardial Infarction in Sepsis
by: Meng-Ko Tsai, et al.
Published: (2022) -
Troponin I level in risk stratification of non-ST-elevation myocardial infarction in smokers
by: Iram Shahriar, Shahina Sobhan and Ziarrat Islam
Published: (2010) -
Troponin I level in risk stratification of non-ST-elevation myocardial infarction in smokers
by: Iram Shahriar, et al.
Published: (2011)